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Abstract
The classical, genomic mechanisms of steroid hormone action cannot account for their rapid cellular effects. Membrane-
bound steroid receptors have been partially characterized, but many rapid steroid effects occur in the absence of
steroid-protein binding. Although it has been proposed that these effects could be due to steroid-induced biophysical
alterations of the cell membrane, only indirect supporting evidence for this hypothesis has been forthcoming. In the present
 .study, the ability of cortisol and estradiol E , natural steroids of different lipophilicity, to induce alterations in a model2
 .membrane lecithin bilayer was examined directly by small-angle X-ray diffraction under physiologic-like conditions.
Within minutes, both steroids partitioned to distinct sites in the membrane. With increasing membrane cholesterol content,
cortisol was displaced toward the polar headgroup region of the phospholipid bilayer, whereas E was displaced in the2
 .opposite direction, toward the nonpolar hydrocarbon core. Membrane-based partition coefficients K p for bothwmemx
 .steroids )100:1 were highest at those cholesterol concentrations that displaced the steroids toward the headgroup region
 .high cholesterol for cortisol; low for E . Both steroids, when located in the headgroup region, increased overall bilayer2
˚width by 3–4 A, a change that could modulate the structure and function of integral membrane proteins independent from
steroid effects on the genome. q 1998 Elsevier Science B.V.
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The tertiary structures of integral membrane pro-
teins are sensitive to changes in the composition and
w xstructure of the surrounding lipid matrix 1–3 . Mod-
ulation of lipid bilayer dynamics can alter
membrane-bound protein function, resulting in the
w xloss of normal membrane physiology 1,4 . Some
rapid cellular effects of steroids may be related to
their intercalation into the membrane lipid bilayer,
but there is only indirect support for the hypothesis
that steroids alter the biophysical properties of cell
) Corresponding author. Fax: q1 412 359 6390.
membranes. In this study, we determined whether
two naturally occurring steroid hormones of different
lipophilicity are capable of altering the biophysical
properties of a model membrane bilayer. Membrane-
based partition coefficients of the steroids were mea-
sured, and small-angle X-ray diffraction was used to
directly determine the spatial distribution of the
steroids in the membrane bilayer and changes in
bilayer width.
Steroid hormones are derived from cholesterol,
which readily partitions into the phospholipid bilayer,
with the 3-hydroxyl group oriented near the surface
of the bilayer in the polar phosphate headgroup re-
0005-2736r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
 .PII S0005-2736 97 00227-7
( )G.A. Golden et al.rBiochimica et Biophysica Acta 1368 1998 161–166162
gion and the sterol nucleus located in the upper
w xhydrocarbon core region 5 . The sterol nucleus is a
rigid, planar, fused-ring structure, which greatly hin-
ders the intrinsic motion of membrane fatty acyl
chains, thereby increasing membrane bilayer width
and reducing lipid mobility. The presence of choles-
terol in the membrane modulates bilayer width and
lipid dynamics. Cholesterol also affects the ability of
certain lipophilic molecules to partition into the
w xmembrane bilayer 6,7 and alters their energetically-
w xfavorable locations within the bilayer 7 . Considering
the close structural homology between cholesterol
 .and steroid hormones Fig. 1 , it is reasonable to
predict that these hormones also can induce mem-
brane structural changes and that their partitioning
into the membrane is affected by cholesterol content.
Heretofore, these interactions have not been tested
directly.
Sample preparation: Lecithinrcholesterol multi-
 .lamellar vesicles MLV were prepared from 1-palmi-
 .toyl-2-oleoyl-sn-glycero-3-phosphocholine POPC in
the presence and absence of cholesterol. POPC and
cholesterol, both solubilized in chloroform, were ob-
 .tained from Avanti Polar Lipids Alabaster, AL and
stored in a desiccator at y208C. Cortisol Sigma, St.
. Louis, MO or 17-b-estradiol Research Biochemi-
.cals International, Natick, MA , solubilized in ethanol,
was added to aliquots of cholesterol and phospholipid
 .in mole ratios C:P of 0.2:1, 0.5:1, and 0.8:1 to yield
a final concentration of 1:30 cortisol- or E -to-phos-2
pholipid mass ratio. The mixture was dried under N2
gas and residual solvent was removed by vacuum.
 .Buffer 154 mM NaCl, 0.5 mM HEPES, pH 7.4, 378C
was added to each tube, yielding a final lipid concen-
tration of 2.5 mgrml, and the solutions were vortexed
w xto form MLV 8 . Steroid-free MLV also were pre-
pared as controls. Stacked membrane bilayers were
formed by centrifugation of the vesicles at 35 000=g
for 90 min at 378C. The supernatants were removed,
and each bilayer pellet was mounted on a curved
glass support and suspended in a humidity chamber
overnight containing a saturated salt solution
 .NH H PO in the vicinity of the sample, establish-4 2 4
ing a relative humidity of 93%. The oriented mem-
brane samples then were placed in sealed brass canis-
ters with thin aluminum foil windows in which tem-
perature and relative humidity were controlled as
.described above .
Small-angle X-ray diffraction: This technique can
directly determine changes in membrane bilayer width
and electron density distribution caused by the addi-
w xtion of small molecules to lipid bilayers 9 . It has
 .Fig. 1. Cholesterol is an amphipathic, planar molecule composed of four fused-rings sterol nucleus . Various enzymes add, remove and
modify constituent groups at different sites on the rings to form the steroid hormones. With only two polar hydroxyl constituent groups,
 .E is less polar possesses greater lipophilicity than cortisol.2
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been used to identify the membrane locations of such
w xlipophilic molecules as cholesterol 10–13 , calcium
w x w xchannel blockers 14 , and anesthetics 5 .
Structural analyses of membrane samples were
carried out by aligning them at grazing incidence
with respect to the X-ray beam. The radiation source
was a collimated, monochromatic X-ray beam CuK ,a
˚ .ls1.54 A produced by a high-brilliance rotating
anode microfocus generator Rigaku Rotaflex RU-
.200, Danvers, MA . The fixed geometry beamline
incorporated a single Franks mirror, providing
 .nickel-filtered radiation K and K unresolveda1 a 2
at the detection plane. The beam height at the sample
was ;3 mm. The diffraction data were collected on
a one-dimensional, position-sensitive electronic de-
 .tector Innovative Technologies, Newburyport, MA
calibrated with cholesterol monohydrate crystals. The
sample-to-detector distance was 150 mm.
Fourier transformation of the diffraction data
yielded the electron density distribution of the mem-
brane. Each individual meridional diffraction peak
was background-corrected by averaging the noise.
 .  .Fig. 2. Electron density profiles of model membrane bilayers at 0.2:1, 0,5:1, and 0.8:1 cholesterol:phospholipid ratios C:P , with - - -
 .  .  .and without added cortisol a, b, c or estradiol d, e, f . Increases in electron density correspond to the energetically
favorable locations of the steroids. Regional increases in electron density are only labeled for one-half of each profile.
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The intensity functions were corrected by a factor of
ss2 sinurl, the Lorentz correction, in which l is
˚ .the wavelength of radiation 1.54 A , and u is the
Bragg angle one-half the angle between the incident
.beam and the scattered beam . Swelling analysis was
used to assign a phase combination to the structure
w xfactors 15 .
Sample preparation for Membrane Partition Coef-
 .  .ficients K p : The K p is an equilibriumwmem x wmemx
value expressing the relative concentration of a sub-
stance in the membrane versus aqueous buffer and
provides an accurate measure of a substance’s affin-
ity for the membrane bilayer. MLV were prepared at
C:P mole ratios of 0:1, 0.2:1, 0.4:1, 0.6:1, 0.8:1, and
1.0:1 with added cortisol or E 1:30 steroid:phos-2
.pholipid mass ratio , as described above. Control
samples contained steroid and buffer, but no phos-
pholipid or cholesterol. The samples were centrifuged
for 30 min at 35 000=g and 378C, and the super-
natants were removed and assayed for steroid con-
tent. The steroid concentration of each sample was
subtracted from the corresponding control value; the
difference represented the amount of steroid con-
tained within the MLV. K p were calculated atwmemx
each cholesterol concentration as follows:
K pwmem x
s g Steroid bound to membranerg Lipid r .
g Free steroidrg Buffer . .
Assay procedures: Cortisol concentrations were
determined in duplicate with a solid-phase coated
. tube radioimmunoassay kit Diagnostic Products
.Corporation, Los Angeles, CA . The minimum de-
tectable cortisol concentration was 1.0 ngrml, and
intra-assay and inter-assay coefficients of variation
were F5.9% and F5.4%, respectively. E concen-2
trations were determined in duplicate with a double-
antibody radioimmunoassay kit Diagnostic Systems
.Laboratories, Webster, TX . The minimal detectable
E concentration was 1.4 pgrml, and intra-assay and2
inter-assay coefficents of variation were F3.9% and
F4.2%, respectively.
Representative electron density distribution pro-
files are shown in Fig. 2. They indicate the time-aver-
aged spatial distribution of membrane phospholipids
as a function of distance across a single bilayer.
Regional increases in electron density associated with
the addition of steroid indicate that cortisol and E2
interacted at distinct sites in these model membrane
bilayers. The locations of both steroids were affected
by cholesterol content in a concentration-dependent
 .manner Table 1 and Fig. 2 : Increasing cholesterol
content displaced cortisol from the bilayer core to the
 .membrane surface phospholipid headgroup region ,
whereas the opposite occurred with E . Both steroids,2
when located in the headgroup region, increased
˚overall bilayer width by 3–4 A. This increase could
w xdeform transmembrane proteins 16 and suggests a
structural mechanism by which steroids could influ-
ence cellular function independently from their ge-
nomic effects.
For the proposed mechanism to account for rapid
steroid effects, the membrane structure changes in-
duced by steroids must occur in the same short time.
We therefore, also examined the kinetic and equilib-
rium binding properties of cortisol and E . The time2
required for both cortisol and E to reach equilibrium2
binding was F5 min, since maximal binding oc-
curred within 5 min, and no significant changes in
K p occurred between 5 and 120 min p)0.3;wmemx
.data not shown . This time-frame is compatible with
Table 1
 .Energetically favorable equilibrium binding distribution "distance from center of membrane for cortisol and estradiol in
 .POPCrcholesterol membranes at various cholesterol:phospholipid mole ratios C:P , as determined by small angle X-ray diffraction.
 .Changes in bilayer width d-space are indicated for each condition
0.2:1 C:P 0.5:1 C:P 0.8:1 C:P
˚ ˚ ˚ ˚ ˚ ˚ .  .  .  .  .  .Location A d-Space change A Location A d-Space change A Location A d-Space change A
a .  .  .Cortisol " 0–9 y0.2 " 10–19 1.5 " 13–31 2.9
a .  .  .E " 13–32 4.0 " 11–30 1.5 " 0–9 y0.72
a  .d-Space significantly different from control membrane bilayer p-0.05, ns3 .
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rapid steroid effects that have been reported in cells
and reasonably excludes early genomic effects.
As mentioned, cholesterol is a major constituent of
mammalian cell plasma membranes and modulates
w x w xmembrane structure 13 and function 17 . As shown
in Fig. 3, K p for both cortisol and E varied as awmemx 2
function of membrane cholesterol content over a
range of 0:1–1.0:1 C:P. At low C:P levels, the E2
K p was inversely and significantly correlatedwmemx
 .with cholesterol content p-0.05 , whereas the cor-
tisol K p decreased only slightly. In contrast, atwmemx
higher C:P levels, E binding was unaffected by2
further cholesterol increases, whereas cortisol binding
was significantly increased.
There are several lines of experimental evidence
which support the possibility that the concentrations
of steroids used in these experiments are biologically
relevant. The biological activity of a hormone gener-
ally is considered to be proportional to its free con-
w xcentration in plasma 18 . Alternatively, it has been
suggested that intracapillary protein-bound hormone
dissociation is sufficiently rapid relative to tissue
uptake and metabolism that the in vivo free-hormone
level is maintained at its in vitro equilibrium value at
w xall times 18 . Additionally, because of local steroid
synthesis from cholesterol, it is likely that certain
w xcells, including neurons 19–21 , are exposed to
steroid concentrations greater than those in the
plasma. Finally, in consideration of the high mem-
brane-binding affinities of steroids, as shown here
w xand elsewhere 22 , it is possible that the plasma
membrane acts as a sink for steroid hormones, allow-
ing them to attain membrane concentrations consider-
ably higher than their circulating levels.
 .It is unclear exactly which factor s contributed to
the pronounced effect of cholesterol content on steroid
location in the membrane. The highest binding con-
centrations and greatest effects on membrane width
occurred for both cortisol and E when they were2
located in the headgroup region of the membrane
bilayer, suggesting more favorable binding properties
andror greater volume availability in this region.
This occurred at different C:P ratios for the two
steroids and suggests a potential nongenomic mecha-
nism for specificity of steroid action, based on the
composition of a given membrane and the molecular
 .structure of a given steroid Fig. 1 . Because plasma
membrane C:P varies considerably among cell types
w x23–25 , it is possible that the same steroid could
have different membrane-based actions in vivo, de-
pending on the lipid composition of the target cell
membrane. The issue of membrane composition also
is relevant for genomic steroid actions, since the
ability of a substance to partition into the membrane
is a critical determinant of its bioavailability to intra-
cellular receptors.
In conclusion, these experiments provide addi-
tional insight into biochemical and biophysical
steroid-membrane interactions which may contribute
to rapid membrane-mediated steroid effects. These
 .  .  .  .Fig. 3. Mean "SEM membrane-based partition coefficients K p for cortisol ns8 and estradiol ns8 in POPCrcholesterolwmemx
 .multilamellar vesicles. K p significantly different than K p at 0.2:1 C:P, p-0.05 .wmemx wmemx
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effects include, among others, modulation of calcium
w x w xflux 26 , augmentation of cAMP effects 27 , and
vasodilation of coronary and peripheral vascular beds
w x28 .
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